Faktor-Faktor Prognostik Kesintasan 5 Tahun Leukemia Limfoblastik Akut Pada Anak Usia 1 - 18 Tahun
Abstract
Leukemia limfoblastik akut (LLA) adalah jenis kanker yang disebabkan oleh akumulasi limfoblas di sumsum tulang yang mempengaruhi banyak anak. Keberhasilan pengobatan pada pasien leukemia dapat dinilai berdasarkan tingkat kelangsungan hidup pasien LLA. Tujuan dari penelitian ini adalah untuk mengidentifikasi kelangsungan hidup 5 tahun, faktor-faktor yang mempengaruhinya, dan nilai skor prediktor kelangsungan hidup pada anak usia 1-18 tahun yang didiagnosis dengan leukemia limfoblastik akut (LLA) di RSAB Harapan Kita. Penelitian ini adalah penelitian observasional analitik yang menggunakan desain penelitian kohort retrospektif. Sampel adalah 130 pasien LLA yang didiagnosis pada tahun 2013-2014 yang diperoleh dari teknik pengambilan sampel non-probabilitas jenis consecutive sampling. Data dikumpulkan dengan melacak rekam medis pasien. Data dianalisis menggunakan analisis Kaplan-Meier dan Regresi Cox. Hasil penelitian menunjukkan bahwa probabilitas tingkat kelangsungan hidup pasien LLA dari 2013-2019 adalah 92,25% dengan tingkat kelangsungan hidup rata-rata 60 bulan. Tingkat kelangsungan hidup pasien LLA 1, 3, dan 5 tahun adalah 97,68%, 93,8%, dan 92,25%. Berdasarkan analisis multivariat menggunakan model interaksi regresi Cox, faktor yang paling berpengaruh pada tingkat kelangsungan hidup pasien LLA adalah komorbiditas (p = 0,002; HR = 10,76 CI; 2,38-48,55), remisi (p = 0,001; HR = 13,28 CI2,98- 59,73) dan kambuh (p = 0,014; HR = 7,92 CI; 1,53-41,12)
References
Hockenberry M, Wilson D, Rodgers CC. Wong’s Essentials of Pediatric Nursing. Tenth Edit. St. Louis, Missouri: Elsevier; 2017.
Hoffbrand VA, Moss PAH. Hoffbrand’s Essential Haematology [Internet]. Seventh Ed. United Kingdom: Wiley Blackwell; 2016. Available from: www.wiley.com/buy/978111840864
Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol [Internet]. 2018;5(1):e14–24. Available from: http://dx.doi.org/10.1016/S2352-3026(17)30232-6
Kementerian Kesehatan R. Situasi Penyakit Kanker. Bul Jendela Data dan Inf Kesehat. 2015;9–10.
WHO. Indonesia Source GLOBOCAN 2018. Int Agency Res Cancer [Internet]. 2019;256:1–2. Available from: http://gco.iarc.fr/
Hockenberry M, Wilson D, Rodgers CC. Wong’s Essentials of Pediatric Nursing. Tenth Edit. St. Louis, Missouri: Elsevier; 2017.
Kleinbaum DG. Survival Analysis: A Self-Learning Text. Third Edit. Gail, M; Krickeberg, K; Samet, J.M; Tsiatis, A; Wong W, editor. Springer. USA: Springer; 2013.
Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, et al. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol. 2017;4(5):e202–17.
Wijayanti LP, Supriyadi E. Faktor prognostik dan kesintasan pasien leukemia limfoblastik akut anak di RSUP Dr. Sardjito, Yogyakarta, 2010–2015. Indones J Cancer. 2017;11(4):145–50.
Lustosa de Sousa DW, de Almeida Ferreira FV, Cavalcante Félix FH, de Oliveira Lopes MV. Acute lymphoblastic leukemia in children and adolescents: Prognostic factors and analysis of survival. Rev Bras Hematol Hemoter [Internet]. 2015;37(4):223–9. Available from: http://dx.doi.org/10.1016/j.bjhh.2015.03.009
Simanjorang C, Kodim N, Tehuteru ES. Perbedaan Kesintasan 5 Tahun Pasien Leukemia Limfoblastik Akut dan Leukemia Mieloblastik Akut pada Anak di Rumah Sakit Kanker “Dharmais.†Indones J Cancer. 2013;7(1):15–21.
Widnyana AANKP. Angka kesintasan dan faktor yang memengaruhi pasien leukemia limfoblstik akut pada anak di RS Sanglah tahun 2010-2012. Universitas Indonesia; 2015.
Elisafitri R, Arsin A, Wahyu A. kesintasan pasien leukemia limfoblastik akut pada anak di RSUP DR. Wahidin Sudirohusodo Makassar. JKMM. 2018;ISSN 2599-:281–90.
Fitriyani et,al. Angka Kejadian dan Faktor yang Memengaruhi Potensi Interaksi Obat dengan Obat pada Pasien Leukemia Akut Anak yang Menjalani Rawat Inap. Sari Pediatri, Vol. 18, No. 2. RSUPN Dr. Cipto Mangunkusumo, Jakarta. 2016
Iran: a cross-sectional study. Cancer Chemotheraphy Pharmacology 2013;71:1619-27.
O’Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: An analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056–61.
Teuffel O, Stanulla M, Cario G, Ludwig WD, Rottgers S, Schafer BW, et al. Anemia and survival in childhood acute lymphoblastic leukemia. Haematologica. 2008;93(11):1652–7.
Ng SM, Lin HP, Ariffin WA, Zainab AK, Lam SK, Chan LL. Age, sex, haemoglobin level, and white cell count at diagnosis are important prognostic factors in children with acute lymphoblastic leukemia treated with BFM-type protocol. J Trop Pediatr. 2000;46(6):338–43
Almasi-Hashiani A, Zareifar S, Karimi M, Khedmati E, Mohammadbeigi A. Survival rate of childhood leukemia in Shiraz, Southern Iran. Iran J Pediatr. 2013;23(1):53–9.
Vora A. Childhood Acute Lymphoblastic Leukemia. Switzerland: Springer; 2017.
Tomlinson D, Kline NE. Pediatric Oncology Nursing: Advance clinical Handbook. Second Edi. New York, USA: Springer; 2010. 587 p.
Li SD, Chen YB, Li ZG, Wu RH, Qin MQ, Zhou X, et al. Infections during induction therapy of protocol CCLG-2008 in childhood acute lymphoblastic leukemia: A single-center experience with 256 cases in China. Chin Med J (Engl). 2015;128(4):472–6.
Bosnjak. Treatment of a Fibrile Neutropenic Patient, Arch Oncol. Vol 12, pp 179-81. 2004
Pojoh, V. S., Mantik, M. F. J., & Manoppo, J. I. C. Hubungan Indeks Massa Tubuh dan Tercapainya Remisi pada Anak Penderita Leukemia Limfoblastik Akut. E-CliniC, Vol. 18, No. 1, Hal 91–99.
Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children’s oncology group. J Clin Oncol. 2012;30(14):1663–9.
Lanzkowsky P, Lipton JM, Fish JD. LANZKOWSKY’S MANUAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY [Internet]. Sixth Edit. The Surgery of Childhood Tumors. United Kongdom: Elsevier; 2016. Available from: http://www.elsevier.com/
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-Non Commercial License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
The content of this website is licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. 
